Focused Alpha’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$354K Buy
19,460
+563
+3% +$10K 0.09% 198
2026
Q2
$303K Buy
18,897
+2,091
+12% +$34.6K 0.08% 222
2026
Q1
$311K Buy
16,806
+2,626
+19% +$46.1K 0.1% 205
2025
Q4
$221K Buy
+14,180
New +$203K 0.07% 228

Other funds holding TAK

Focused Alpha's TAK Position: Q3 2026 in Review

Focused Alpha increased its Takeda Pharmaceutical (TAK) stake by 3% in Q3 2026, buying an estimated $10K and bringing the position to 19,460 shares worth $354K. The position accounts for 0.09% of the portfolio, ranked #198.

Focused Alpha first reported a position in TAK in Q4 2025 and has held it in 4 quarters since. 332 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Focused Alpha held 19,460 shares of Takeda Pharmaceutical worth $354K as of Q3 2026.
  • Focused Alpha bought 563 Takeda Pharmaceutical shares in Q3 2026, an estimated $10K.
  • Takeda Pharmaceutical made up 0.09% of Focused Alpha's portfolio in Q3 2026, its #198 holding.
  • Focused Alpha first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 4 quarters since.
  • 332 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.